CorVel (CRVL)
Manages insurance claims and medical costs through patient management and network solutions.
$73.46
vs last close−0.13 (−0.18%)
In millions of USD, except per-share figures
| In millions | Q2 FY24Sep 2023 | Q3 FY24Dec 2023 | Q4 FY24Mar 2024 | Q1 FY25Jun 2024 | Q2 FY25Sep 2024 | Q3 FY25Dec 2024 | Q4 FY25Mar 2025 | Q1 FY26Jun 2025 | Q2 FY26Sep 2025 | Q3 FY26Dec 2025 | Q4 FY26Mar 2026 | Q1 FY27Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 196 | 202 | 207 | 212 | 224 | 228 | 232 | 235 | 240 | 236 | 249 | 260 |
| Cost of revenue | 151 | 160 | 164 | 164 | 174 | 175 | 174 | 178 | 181 | 181 | 186 | 201 |
| Gross profit | 44 | 42 | 43 | 48 | 51 | 53 | 58 | 57 | 58 | 55 | 63 | 59 |
| 20 | 20 | 21 | 20 | 22 | 22 | 25 | 21 | 22 | 23 | 23 | 16 | |
| 20 | 20 | 14 | 20 | 22 | 22 | 25 | 21 | 22 | 23 | 89,666 | 1 | |
| Selling & marketing | 0 | 0 | −7 | 0 | 0 | 21 | 0 | 0 | 0 | 0 | 0 | 0 |
| General & administrative | 20 | 20 | 21 | 20 | 22 | 1 | 25 | 21 | 22 | 23 | 89,666 | 1 |
| Other expenses | 0 | 0 | 7 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | −89,642 | 15 |
| Operating income | 25 | 22 | 23 | 28 | 29 | 31 | 33 | 35 | 36 | 32 | 40 | 43 |
| Income before tax | 25 | 22 | 23 | 28 | 29 | 31 | 33 | 35 | 36 | 32 | 40 | 43 |
| Income tax expense | 5 | 5 | 3 | 6 | 5 | 7 | 7 | 8 | 8 | 8 | 9 | 11 |
| Net income from continuing operations | 20 | 17 | 19 | 22 | 23 | 24 | 26 | 27 | 28 | 24 | 31 | 32 |
| Net income | 20 | 17 | 19 | 22 | 23 | 24 | 26 | 27 | 28 | 24 | 31 | 32 |
| EPS, basic | $0.39 | $0.33 | $0.38 | $0.42 | $0.46 | $0.46 | $0.51 | $0.53 | $0.54 | $0.47 | $0.61 | $0.63 |
| EPS, diluted | $0.38 | $0.33 | $0.37 | $0.42 | $0.45 | $0.46 | $0.51 | $0.52 | $0.54 | $0.47 | $0.61 | $0.63 |
| Weighted average shares, basic | 51 | 51 | 51 | 51 | 51 | 51 | 51 | 51 | 51 | 51 | 51 | 51 |
| Weighted average shares, diluted | 52 | 52 | 52 | 52 | 52 | 52 | 52 | 52 | 52 | 52 | 51 | 51 |
| EBITDA | 31 | 29 | 29 | 35 | 36 | 38 | 41 | 43 | 44 | 40 | 48 | 52 |
| Depreciation & amortization | 6 | 7 | 7 | 7 | 8 | 7 | 8 | 8 | 8 | 8 | 8 | 9 |
| EBIT | 25 | 22 | 23 | 28 | 29 | 31 | 33 | 35 | 36 | 32 | 40 | 43 |